Clinical Trials Browser

Phase 4 × Kaposiform Hemangioendothelioma × Clear all

NCT04448873 2023-09-26

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Phase 4 Completed

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome

NCT04077515 2023-01-30

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Phase 4 Completed

Kaposiform Hemangioendothelioma, Hemangioma, Kasabach-Merritt Syndrome